Searched for
SPECIALITY ONCOLOGY THERAPY
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...
- Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisitionZydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Ajay Hinduja on advancing cancer care: Insights on CAR-T therapy innovationIndia has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. ...
- Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...
- Centre of Excellence for cancer care and blood disorders at Amrita Hospital, FaridabadAmrita Hospital's Department of Hematology, Medical Oncology and BMT helps patients treat blood disorders, benign diseases, as well as bloo...
- ICMR nod to pvt hospital to try plasma therapy for COVID-19 patientsThis was stated by the Drugs Controller General of India in a letter to to HCG Bangalore Institute of Oncology Speciality Centre. The permi...
- Eyeing over 80% sales from US, India, Europe by 2021: GlenmarkAs part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentatio...
- Philips Healthcare to provide proton cancer therapy with IBA in IndiaPhilips Healthcare has entered into an exclusive agreement with Belgium-headquartered IBA to provide proton therapy solutions in India.
- Health Ministry to check if Pharma FDI policy mars public healthHealth ministry will hold an inter-ministerial meeting to ensure that the existing FDI in the pharma sector is not at variance with the pub...
- Cancer medicines for as low as Rs 1,000 a month on wayTata Memorial Hospital’s doctors are working on alternatives that could cost less than Rs 1,000 a month.
- Apollo invests Rs 75 cr on ASCH with Cyberknife robotic facilityCorporate healthcare pioneer Apollo Hospitals has invested Rs 75 crore on setting up a speciality cancer hospital in the heart of the city.
- Zenotech to market Ranbaxy’s oncology products in N AmericaRanbaxy on Wednesday announced a strategic tie-up with Hyderabad-based Zenotech Laboratories for marketing the latter’s oncology products i...
Load More
